Biomarker composition for diagnosing radiation exposure comprising lipid metabolites and method for diagnosing using the biomarker

摘要

TECHNICAL FIELD The present invention relates to a biomarker composition for diagnosing radiation exposure and a use thereof, and more particularly, to a radiation exposure diagnostic kit using a lipid metabolite that is increased by radiation exposure in human fibroblasts as a biomarker . In addition, by providing a diagnostic method by comparing the changes of the lipid metabolism biomarker of the biological sample separated from the sample and the lipid metabolism biomarker separated from the normal control group, it is possible to quickly and efficiently diagnose the exposure and the degree of exposure of the suspected patient It is possible to improve the therapeutic effect on a radiation exposed patient.